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Abstract
Objective To examine the association between physical activity and
risk of ulcerative colitis and Crohn’s disease.
Design Prospective cohort study.
Setting Nurses’ Health Study and Nurses’ Health Study II.
Participants 194 711 women enrolled in the Nurses’ Health Study and
Nurses’ Health Study II who provided data on physical activity and other
risk factors every two to four years since 1984 in the Nurses’ Health
Study and 1989 in the Nurses’ Health Study II and followed up through
2010.
Main outcome measure Incident ulcerative colitis and Crohn’s disease.
Results During 3 421 972 person years of follow-up, we documented
284 cases of Crohn’s disease and 363 cases of ulcerative colitis. The
risk of Crohn’s disease was inversely associated with physical activity
(P for trend 0.02). Compared with women in the lowest fifth of physical
activity, the multivariate adjusted hazard ratio of Crohn’s disease among
women in the highest fifth of physical activity was 0.64 (95% confidence
interval 0.44 to 0.94). Active women with at least 27 metabolic equivalent
task (MET) hours per week of physical activity had a 44% reduction
(hazard ratio 0.56, 95% confidence interval 0.37 to 0.84) in risk of
developing Crohn’s disease compared with sedentary women with <3
MET h/wk. Physical activity was not associated with risk of ulcerative
colitis (P for trend 0.46). The absolute risk of ulcerative colitis and Crohn’s
disease among women in the highest fifth of physical activity was 8 and
6 events per 100 000 person years compared with 11 and 16 events
per 100 000 person years among women in the lowest fifth of physical
activity, respectively. Age, smoking, body mass index, and cohort did
not significantly modify the association between physical activity and
risk of ulcerative colitis or Crohn’s disease (all P for interaction >0.35).
Conclusion In two large prospective cohorts of US women, physical
activity was inversely associated with risk of Crohn’s disease but not of
ulcerative colitis.
Introduction
Ulcerative colitis and Crohn’s disease, collectively known as
inflammatoryboweldisease,arechronicinflammatorydisorders
of the gastrointestinal tract affecting nearly 1.4 million
Americans. Inflammatory bowel disease accounts for over $6
bnindirecthealthcarecostsannually.
1Inaddition,inflammatory
bowel disease is associated with important indirect costs, loss
of economic productivity, and work disability.
2 3
Although the exact pathophysiology of Crohn’s disease and
ulcerative colitis remains largely unknown, findings from
ecologic studies,
4 the rising incidence in inflammatory bowel
diseaseoverthepastseveraldecades,
5andtherelativelymodest
riskcontributionfromknowngeneticriskloci(<15%),
6highlight
the importance of the environment in the development of
inflammatory bowel disease. To date, few environmental risk
factors have been identified.
Correspondence to: A T Chan achan@partners.org
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Research
RESEARCHRecent in vivo studies have shown that exercise may induce
autophagy, a lysosomal degradation pathway known to protect
against diseases such as cancer, neurogenerative disorders,
infections, and inflammatory disorders.
7 In parallel, genome
wide association studies have identified susceptibility loci to
Crohn’s disease within autophagy pathways, suggesting a
possible mechanistic association between physical activity and
risk of inflammatory bowel disease.
Weexaminedtheassociationbetweenphysicalactivityandrisk
of Crohn’s disease and ulcerative colitis in two large ongoing
prospective cohort studies of US women, the Nurses’ Health
Study and Nurses’ Health Study II. With more than 20 years of
biennially updated and validated data on lifestyle, diet, and
medical diagnoses, these cohorts offered us the unique
opportunitytoexaminetheassociationbetweenphysicalactivity
assessed at multiple time points over adulthood and subsequent
risk of ulcerative colitis and Crohn’s disease in the context of
other potential risk factors.
Methods
Study population
The Nurses’ Health Study is a prospective cohort that began in
1976 when 121 700 US female registered nurses, aged 30 to 55
years, completed a mailed health questionnaire. Follow-up
questionnaires are mailed every two years to update health
information.In1989,aparallelcohort,theNurses’HealthStudy
II, enrolled 116 686 US female registered nurses between the
agesof25and42years.Thesewomenhavebeenfollowedwith
similar biennial questionnaires. The figure⇓ provides detailed
informationaboutthenumberofparticipantswhowereexcluded
at baseline, were eligible for analyses, and were lost to
follow-up.
Assessment of physical activity
Starting 1984 in the Nurses’ Health Study and 1989 in the
Nurses’ Health Study II, an assessment of physical activity was
obtainedwhenparticipantswereaskedabouttheiraveragetime
per week during the preceding year spent doing any of the
following activities: walking or hiking outdoors; jogging;
running;bicycling;swimminglaps;tennis;calisthenics,aerobics,
aerobic dance, or rowing machine; squash or racquet ball; and
performing other vigorous activities (for example, mowing the
lawn). Participants also reported their usual outdoor walking
pace:unabletowalk,easyorcasual(<2mph),normaloraverage
(2-2.9 mph), brisk (3-3.9 mph), or very brisk or striding (≥4
mph).Thesequestionswererepeatedin1988,1992,1996,1998,
2000, and 2004 in the Nurses’ Health Study and in 1991, 1997,
2001, and 2005 in the Nurses’ Health Study II (see
supplementary figure). Each activity was assigned a value for
metabolic equivalent task (MET) according to established
criteria.
8Eachparticipant’sMETscoreforwalkingwasassigned
on the basis of her reported walking pace. We calculated the
MET hours per week (MET h/wk) for each activity by
multiplyingtheMETscorebytheparticipant’sreportednumber
of hours of physical activity per week. Total physical activity
was computed as the sum of the MET hours per week from all
individualactivities.VigorousactivitysummedtheMEThours
per week from all the recreational activities listed, excluding
walking.Allactivitiesincludedasvigoroushadintensityscores
of 6 MET or more. To evaluate long term levels of physical
activity during the follow-up, we calculated the cumulative
average of MET scores for all available physical activity
questionnairespriortodiagnosisofCrohn’sdiseaseorulcerative
colitis. We created four variables of updated physical activity,
updatedvigorousphysicalactivity,cumulativeaveragephysical
activity,andcumulativeaveragevigorousactivitybasedondata
from total physical activity, vigorous physical activity, and
cumulative average of total and vigorous physical activity,
respectively. When our detailed assessment was not included
on biennial questionnaires we carried physical activity data
forward from the prior questionnaire cycle (for example, 1988
data used in 1990-92 follow-up). We otherwise did not carry
forward missing data. Women with missing data during a
questionnaire cycle in which physical activity was assessed did
not contribute person years to the analyses.
In a validation study, 151 randomly selected participants from
theNurses’HealthStudyIIweresentquestionnairesonphysical
activity every three months for a year shortly after they
completed the baseline questionnaire.
9 The baseline
characteristics of these participants, including age, body mass
index, and levels of physical activity were similar to that of the
entire cohort. The questionnaires contained a recall of activity
inthepastweektobecompletedonreceiptandanactivitydiary
to be completed daily for the next seven days. At the end of the
year, participants were sent a second physical activity
questionnaireaboutthepreviousyear.ThecorrelationforMET
hours per week of moderate or vigorous activity was strong
(r=0.62), suggesting that the questionnaire is reasonably valid
forrankingparticipants.Forwalking,theprimaryactivityamong
the participants in our analysis, the correlation was 0.70. A
previous study also found moderate levels of reproducibility
during a two year interval (from 1989 through 1991), with a
two year test-retest correlation of 0.59.
9
Assessment of other covariates
On each biennial questionnaire, women were also asked about
pertinent lifestyle factors, including body weight, smoking
status, and use of non-steroidal anti-inflammatory drugs,
hormone therapy, and oral contraceptives. Participants’ self
report of body weight, height, and use of non-steroidal
anti-inflammatory drugs and oral contraceptives have been
previously validated.
10 11 In 1992 in the Nurses’ Health Study
and in 1991 in the Nurses’ Health Study II, women were also
asked their latitude of residence at age 30, which we have
previouslyshowntobeassociatedwithriskofulcerativecolitis
and Crohn’s disease.
12 Information about history of
appendicectomywasalsocollectedin1992intheNurses’Health
Study and in 1995 in the Nurses’ Health Study II.
Outcome ascertainment
We have previously detailed our methods for confirming self
reported cases of Crohn’s disease and ulcerative colitis.
12 13 In
brief, since 1976 participants have reported diagnoses of
ulcerative colitis or Crohn’s disease through an open ended
response on biennial surveys. In addition we have specifically
queried participants about diagnoses of ulcerative colitis since
1982 and Crohn’s disease since 1992. In the Nurses’ Health
Study II we have specifically queried participants about
diagnoses of both ulcerative colitis and Crohn’s disease since
1993. When a diagnosis was reported on any biennial
questionnaire, two gastroenterologists blinded to exposure
information requested and reviewed a supplementary
questionnaire and related medical records.
Weexcludedparticipantswhosubsequentlydeniedthediagnosis
on the supplementary questionnaire or permission to review
their records. Data were extracted on diagnostic tests,
histopathology, anatomic location of disease, and disease
behavior. Using standardized criteria,
14-17 the diagnosis of
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RESEARCHulcerative colitis was based on a typical clinical presentation at
four weeks or less and an endoscopic or surgical pathological
specimen consistent with ulcerative colitis (for example,
evidence of chronicity). The diagnosis of Crohn’s disease was
based on a typical clinical history for four weeks or less and
endoscopy or radiologic evaluation demonstrating small bowel
findings, or surgical findings consistent with Crohn’s disease
combined with pathology suggesting transmural inflammation
orgranuloma.Disagreementswereresolvedthroughconsensus.
Among those women for whom we received adequate medical
records, the case confirmation rate for inflammatory bowel
disease was 78%.
13 Women for whom we did not confirm
Crohn’s disease or ulcerative colitis were included in the
analyses as non-cases. After excluding all cases of Crohn’s
disease and ulcerative colitis at the baseline questionnaire and
among women with missing information on physical activity,
we included 284 incident cases of Crohn’s disease and 363
incident cases of ulcerative colitis. These incidence rates are
largely consistent with those reported in other US
populations.
18-20
Statistical analysis
Person time for participants was calculated from the date of
returnoftheirbaselinequestionnairestothedateofthediagnosis
of ulcerative colitis or Crohn’s disease, date of last returned
questionnaire, or 1 June 2010 for the Nurses’ Health Study and
1 June 2009 for the Nurses’ Health Study II, whichever came
first. At baseline we excluded participants with missing data on
physical activity and a history of inflammatory bowel disease
or cancer (with the exception of non-melanoma skin cancer).
We used Cox proportional hazards modeling with an
Anderson-Gill data structure for time varying covariates to
adjust for other known or suspected risk factors prior to each
two year interval to calculate adjusted hazard ratios and 95%
confidence interval. Because weight may be influenced by
preclinical disease, we adjusted for body mass index using the
baseline value, consistent with prior analyses.
21 We modeled
physical activity in fifths or categorically (<3, 3-<9, 9-<18,
18-<27, and ≥27 MET h/wk) consistent with prior studies.
22
Categories were chosen to correspond to the equivalent of <1,
1-<3, 3-<6, 6-<9, and ≥9 hours of walking at an average pace
per week.
Inseparateanalysesofeachstudyweobservednoheterogeneity
in the association of physical activity with Crohn’s disease or
ulcerative colitis (P for heterogeneity >0.69 for both). Thus we
pooled individual level data from each study and adjusted for
cohort in all analyses. We evaluated the effect of measurement
error in assessing physical activity data on risk of ulcerative
colitis or Crohn’s disease using a previously described risk set
regression calibration method.
23 This analysis was carried out
using cumulatively average updated data on physical activity
with a general linear measurement error model. We also
examined the association between physical activity and risk of
ulcerative colitis or Crohn’s disease according to stratums of
age, smoking, and body mass index and evaluated these for
potential interaction using cross classified categories of these
risk factors and physical activity. We tested the significance of
interactions by using the log likelihood ratio test comparing the
modelwithcrossclassifiedcategorieswithamodelthatincluded
these factors as independent variables. We used SAS version
9.1.3 for these analyses. All P values were two sided and we
considered values <0.05 to be statistically significant.
Results
Through 2010 we documented 284 incident cases of Crohn’s
disease and 363 incident cases of ulcerative colitis among 194
711 women who contributed 3 421 973 person years of
follow-up.Comparedwithwomeninthelowestfifthofphysical
activity, women in the highest fifth were less likely to be obese
(body mass index ≥30) or current smokers (table 1⇓). There
were no significant differences according to age, history of
appendicectomy, and use of non-steroidal anti-inflammatory
drugs,oralcontraceptives,orpostmenopausalhormonetherapy
according to fifths of physical activity.
Compared with women in the lowest fifth of overall physical
activity,theageadjustedriskofCrohn’sdiseasedecreasedwith
increasinglevelofphysicalactivity(table2⇓).Theriskwasnot
significantlyalteredafteradjustingforknownandpotentialrisk
factors for Crohn’s disease, including body mass index,
smoking, appendicectomy, and use of oral contraceptives,
non-steroidal anti-inflammatory drugs, and postmenopausal
hormone therapy (P for trend 0.02). Compared with women in
the lowest fifth of physical activity, the multivariate adjusted
hazard ratio of Crohn’s disease was 0.74 (95% confidence
interval 0.52 to 1.05) for the second fifth of physical activity,
0.88 (0.63 to 1.24) for the third fifth, 0.65 (0.45 to 0.95) for the
fourth fifth, and 0.64 (0.44 to 0.94) for the highest fifth.
According to prespecified categories of activity, the risk of
Crohn’s disease decreased with increasing levels of physical
activity(Pfortrend0.007).Comparedwithwomeninthelowest
category of physical activity (<3 MET h/wk), the multivariate
adjusted hazard ratio of Crohn’s disease was 0.65 (95%
confidence interval 0.44 to 0.95) among those in the 3-<9 MET
h/wk category, 0.73 (0.51 to 1.06) in the 9-<18 MET h/wk
category,0.48(0.30to0.75)inthe18-<27METh/wkcategory,
and 0.56 (0.37 to 0.84) in the ≥27 MET h/wk category. We
estimated that each 10 MET h/wk (equivalent to approximately
2.5hoursofbriskwalkingperweek)increaseinphysicalactivity
was associated with a 6% reduction in risk of Crohn’s disease
(hazard ratio 0.94, 95% confidence interval 0.87 to 1.00). After
correcting for measurement error, we observed a larger, albeit
non-statistically significant effect estimate (hazard ratio 0.83,
95% confidence interval 0.63 to 1.11).
In analyses in which we considered only the baseline report of
physical activity (1986 in the Nurses’ Health Study and 1989
in the Nurses’ Health Study II), we observed a similar trend
withlowerriskofCrohn’sdisease(Pfortrend0.03).Toevaluate
the effect of long term physical activity, we examined the
cumulative average of physical activity data in relation to risk
of Crohn’s disease and observed similar associations (P for
trend 0.01, table 2). Compared with women in the lowest fifth
ofcumulativephysicalactivity,themultivariateadjustedhazard
ratio of Crohn’s disease among women in the highest fifth of
cumulativephysicalactivitywas0.68(95%confidenceinterval
0.46 to 1.01).
As walking accounted for the majority of physical activity
among the participants, we considered the specific effect of
vigorous physical activity, consisting of jogging, running,
biking,swimming,tennis,aerobics,andothervigorousexercises,
on risk of Crohn’s disease (table 2). Compared with women in
the lowest fifth of vigorous physical activity, women in the
highest fifth had a multivariate adjusted hazard ratio of 0.66
(95% confidence interval 0.43 to 1.02, P for trend 0.09).
Similarly, compared with women in the lowest fifth of
cumulativeaverageofvigorousphysicalactivity,womeninthe
highest fifth had a multivariate adjusted hazard ratio of 0.63
(0.42 to 0.95, P for trend 0.02).
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RESEARCHWe explored the possibility that prediagnosis symptoms of
Crohn’sdiseasemayhavelimitedphysicalactivityandtherefore
may account for our observed inverse association. Thus we
performed lag analyses using physical activity data collected at
least four years prior to each two year follow-up interval and
observed similar associations. Compared with women in the
lowest fifth of cumulative average of physical activity, women
in the highest fifth had a multivariate adjusted hazard ratio of
0.71 (0.46 to 1.09, P for trend 0.03). Similarly, compared with
women in the lowest fifth of cumulative average of vigorous
physical activity, women in the highest fifth had a multivariate
adjusted hazard ratio of 0.68 (0.43 to 1.06, P for trend 0.02).
IncontrasttoCrohn’sdisease,wedidnotobserveanassociation
between physical activity and risk of ulcerative colitis (table
3⇓). Compared with women in the lowest fifth of overall
physical activity, the multivariate adjusted hazard ratio of
ulcerative colitis among women in highest fifth of physical
activity was 0.91 (95% confidence interval 0.65 to 1.26). We
also did not observe any association between physical activity
and ulcerative colitis according to prespecified categories (<3,
3 -<9, 9-< 18, 18-< 27, ≥27 MET h/wk) (P for trend 0.42).
Similarly,therewasnoassociationbetweencumulativeaverage
ofphysicalactivityandriskofulcerativecolitis.Comparedwith
women in the lowest fifth of physical activity, women in the
highest fifth had a multivariate adjusted hazard ratio of 0.93
(95%confidenceinterval0.66to1.30).Wealsodidnotobserve
an association between updated (P for trend 0.49) and
cumulative average (P for trend 0.40) assessments of vigorous
physical activity and risk of ulcerative colitis (table 3).
Finally, as body mass index, age, and smoking may modify the
effect of physical activity on risk of Crohn’s disease and
ulcerative colitis, we examined associations according to
stratumsdefinedbythesevariables.Theassociationofphysical
activitywitheitherCrohn’sdiseaseorulcerativecolitiswasnot
modified by age (≤40, >40), body mass index (<25, ≥25), and
smoking (never, ever) (all P for interaction >0.35).
Discussion
IntwolargeprospectivecohortsofUSwomen,physicalactivity
was associated with a lower risk of Crohn’s disease but not of
ulcerative colitis. These results were consistent even after
accounting for known and possible risk factors for Crohn’s
disease, including smoking and body mass index. We observed
that women who engaged in physical activity of more than 27
metabolic equivalent task (MET) hours per week, or the
equivalent of more than nine hours per week of walking at an
average pace, had a 44% lower risk of developing Crohn’s
disease compared with women who were inactive (<3 MET
h/wk). This risk relative reduction translated into a change in
incidence rate of 11 cases per 100 000 person years among
women in the highest category of physical acitivty to 7 cases
per 100 000 person years among those in the lower category of
physical activity.
Comparison with other studies
Our findings are consistent with findings from two prior
case-control studies.
24 25 The first of these studies,
24 using
occupationasaproxyforphysicalactivity,describedaninverse
correlation between occupations involving exercise and risk of
ulcerative colitis and Crohn’s disease. The other study
25 used a
single mailed questionnaire to obtain data on physical activity
from cases and controls and observed an inverse association
between regular physical activity and risk of ulcerative colitis
or Crohn’s disease. Because these case-control studies had
limited ascertainment of physical activity as well as other
lifestyle factors, our cohort analysis, with detailed and updated
informationonactivityandotherknownorputativeriskfactors
for Crohn’s disease, significantly extends these findings. Our
results,however,contrastwiththoseoftheEuropeanProspective
Investigation into Cancer and Nutrition cohort, which failed to
observe a relation between physical activity and risk of
ulcerative colitis and Crohn’s disease.
26 However, this study
included only 67 cases of Crohn’s disease and was unable to
account for changes in physical activity and body mass index
over long term follow-up.
Although our understanding of the pathogenesis of ulcerative
colitis and Crohn’s disease remains incomplete, the discovery
of distinct genetic susceptibility loci for both diseases points to
potential diverging biological pathways.
27 28 Most notably,
genome-wideassociationstudieshaveidentifiedseveraldistinct
candidate genes for Crohn’s disease (for example, ATG16L1,
IRGM)primarilyinvolvedintheregulationofautophagy.Recent
observationsthatphysicalactivitymightinduceautophagymay
therefore explain the unique association between physical
activity and risk of Crohn’s disease.
7 In addition, previous
physiologic and in vitro studies suggest a role for physical
activityinreducingchronicinflammationandregulatinginnate
immunity.
29
Strengths and limitations of this study
Ourstudyhasseveralnotablestrengths.Firstly,ourprospective
study design avoids the potential recall and selection biases of
retrospective, case-control studies that collect data on lifestyle
afterdiagnosisofCrohn’sdiseaseorulcerativecolitis.Secondly,
weconfirmedallcasesofCrohn’sdiseaseandulcerativecolitis
through a review of medical records, a significant advantage
over studies that rely on self report or discharge codes, which
may not accurately reflect true diagnoses. Thirdly, the
availability of detailed and validated information on body mass
index, prior oral contraceptive use, and smoking allowed us to
controlforseveralpotentialriskfactorsthatmayhaveinfluenced
ourobservedassociations.Fourthly,inouranalysiswecollected
information on physical activity every two to four years and
used time varying exposures in our Cox models. Thus we were
able to account for changes in participants’ physical activity
level over time, minimizing the possibility of exposure
misclassification. Lastly, our validation study
9 demonstrated
that our participants self reported physical activity is relatively
valid and reproducible.
We acknowledge several limitations. Firstly, our cohort may
not be representative of the overall US population. However,
as we have previously reported,
12 our age specific incidence of
Crohn’sdiseaseandulcerativecolitisarelargelysimilartorates
from other US populations. In addition, previous studies have
shown that the prevalence of risk factors, such as smoking and
body mass index, in our cohort are consistent with those of the
broader population of US women.
30 31 Secondly, despite our
high follow-up rate over 20 years and participants’ health
literacy as nurses, it is possible that some cases of ulcerative
colitis and Crohn’s disease were not reported. However, such
misclassification of the outcome would tend to attenuate our
risk estimates towards the null. Thirdly, we acknowledge that
our observed association may have been influenced by
measurement bias or inaccuracies arising from self reported
measuresofphysicalactivity.However,weobservedconsistent
associations between physical activity and risk of Crohn’s
diseaseandulcerativecolitisacrossdifferentsubgroupsofbody
massindexandsmoking.Inaddition,adjustingformeasurement
errors did not significantly alter our observed risk estimates.
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RESEARCHFourthly, we acknowledge that the mean age at diagnosis of
inflammatory bowel disease in our cohorts is older than the age
at diagnosis of inflammatory bowel disease in the general
population. However, as we have previously shown,
12 13 32 the
distribution of known risk factors (for example, smoking and
use of oral contraceptives), anatomic location, and disease
behavior among women with inflammatory bowel disease in
our cohorts is similar to other population based cohorts. These
findings suggest that our results will likely have relevance to
the greater population of patients with inflammatory bowel
disease. None the less, further studies are needed to examine
theassociationofphysicalactivitywiththeincidenceofCrohn’s
disease with onset at younger ages. Fifthly, our study is
observational and we cannot exclude the possibility of residual
confounding. However, adjustment for the most important risk
factors previously identified for ulcerative colitis and Crohn’s
disease did not appreciably alter our results. Lastly, we
acknowledge that there could be significant between person
heterogeneity in the calculation of energy expenditure from
physicalactivitybasedonfactorssuchaslevelsoffitness,body
size, as well as various environmental factors such as latitude,
external temperature, and humidity. These factors may affect
the accuracy of MET hours per week values as a reflection of
energy expenditure. However, since such biases are
non-differential, it would bias our results towards the null and
therefore could potentially further strengthen our observed
associations.
Conclusion
In two large prospective cohorts of US women, increased
physical activity was associated with a lower risk of Crohn’s
disease but not of ulcerative colitis. Whether these associations
with disease incidence may imply a benefit of physical activity
on disease activity in patients with existing Crohn’s disease is
unclear and merits further study. In addition, further studies on
theeffectofphysicalactivityonriskandprogressionofCrohn’s
diseaseinthecontextofknowngeneticriskfactorsinautophagy
and innate immunity pathways will help elucidate the
mechanism underlying this association. Ultimately, this may
lead to lifestyle interventions among subgroups with known
genetic risk factors for Crohn’s disease to modify the risk of
disease or among patients with established disease to limit its
progression.
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RESEARCHTables
Table 1| Baseline characteristics of participants in Nurses’ Health Study and Nurses’ Health Study II according to fifths of physical activity*.
Values are numbers (percentages) unless stated otherwise
Physical activity (MET h/wk)
Characteristics Highest fifth (n=38 947) 4th fifth (n=39 182) 3rd fifth (n=39 346) 2nd fifth (n=39 119) Lowest fifth (n=38 117)
41.8 (11.3) 42.2 (11.0) 42.2 (10.9) 42.3 (10.8) 42.4 (10.6) Mean (SD) age (years)
Geographical latitude at age
30:
5358 (13.8) 5466 (14.0) 5606 (14.3) 5335 (13.6) 5811 (15.2) Southern
14 773 (37.9) 15 587 (39.8) 15 823 (40.2) 15 831 (40.5) 14 913 (39.1) Middle
11 456 (29.4) 11 600 (29.6) 11 313 (28.8) 11 217 (28.7) 10 318 (27.1) Northern
7360 (18.9) 6529 (16.7) 6604 (16.8) 6736 (17.2) 7075 (18.6) Foreign/unknown
Baseline body mass index:
5926 (15.2) 4808 (12.3) 4443 (11.3) 4282 (11.0) 4198 (11.0) <20
22 302 (57.3) 21 794 (55.6) 20 644 (52.5) 19 107 (48.8) 17 123 (44.9) 20-24.9
7685 (19.7) 8896 (22.7) 9513 (24.2) 9827 (25.1) 9567 (25.1) 25-29.9
3034 (7.8) 3684 (9.4) 4746 (12.0) 5903 (15.1) 7229 (19.0) ≥30
Smoking:
21 809 (56.0) 22 432 (57.2) 22 602 (57.4) 22 219 (56.8) 20 821 (54.6) Never
11 527 (29.6) 11 195 (28.6) 10 640 (27.1) 9762 (25.0) 9368 (24.6) Former
5615 (14.4) 5555 (14.2) 6104 (15.5) 7138 (18.3) 7928 (20.8) Current
4968 (12.8) 4977 (12.7) 4904 (12.5) 5028 (12.9) 4994 (13.1) Regular use of ≥2 tablets/wk
NSAIDs
26 535 (68.1) 26 852 (68.5) 26 932 (68.5) 26 610 (68.0) 25 976 (68.2) Ever use of oral
contraceptives
11 882 (30.5) 11 888 (30.3) 11 905 (30.3) 11 787 (30.1) 11 513 (30.2) Postmenopause
Postmenopausal hormone
use†:
5885 (49.5) 5781 (48.6) 5918 (49.7) 6129 (52.0) 6126 (53.2) Never
2461 (20.7) 2624 (22.1) 2571 (21.6) 2534 (21.5) 2494 (21.7) Former
3536 (29.8) 3483 (29.3) 3416 (28.7) 3124 (26.5) 2893 (25.1) Current
6627 (17.0) 6879 (17.6) 6999 (17.8) 6906 (17.7) 6716 (17.6) History of appendicectomy
MET h/wk=metabolic equivalent task hours per week.
*Values are standardized to age distribution of study population. All variables are derived from baseline questionnaires (1986 in Nurses Health Study and 1989 in
Nurses Health Study II) with exception of geographic location (1992 and 1993, respectively), oral contraceptive use (1984 and baseline, respectively), and
appendicectomy (baseline and 1995, respectively).
†Percentages among postmenopausal women.
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RESEARCHTable 2| Physical activity and risk of Crohn’s disease in Nurses’ Health Study and Nurses’ Health Study II (1984-2010)
P for trend
Physical activity fifth
Variables Highest 4th 3rd 2nd Lowest
Updated physical activity*:
45.2 (33.2) 21.5 (5.0) 11.2 (2.9) 5.1 (1.8) 1.0 (1.0) Median (SD) MET h/wk
47 48 63 54 72 No of cases
688 514 692 548 689 222 684 398 667 291 Person years
0.005 0.60 (0.42 to 0.87) 0.61 (0.42 to 0.88) 0.83 (0.59 to 1.17) 0.71 (0.50 to 1.02) 1.00 Age adjusted (95% CI)
0.02 0.64 (0.44 to 0.94) 0.65 (0.45 to 0.95) 0.88 (0.63 to 1.24) 0.74 (0.52 to 1.05) 1.00 Multivariable adjusted (95% CI)†
Cumulative average physical
activity (MET h/wk):
41.4 (29.9) 21.6 (5.0) 13.0 (3.1) 7.2 (2.1) 2.6 (1.5) Median (SD) MET h/wk
46 50 63 66 59 No of cases
681 317 724 306 720 478 694 609 601 262 Person years
0.005 0.65 (0.44 to 0.95) 0.67 (0.46 to 0.98) 0.88 (0.62 to 1.25) 0.95 (0.67 to 1.35) 1.00 Age adjusted (95% CI)
0.01 0.68 (0.46 to 1.01) 0.71 (0.47 to 1.03) 0.92 (0.64 to 1.32) 0.98 (0.69 to 1.40) 1.00 Multivariable adjusted (95% CI)†
Updated vigorous physical
activity‡ (MET h/wk):
28.5 (29.8) 8.8 (5.1) 4.5 (2.4) 0.5 (1.0) 0 (0.02) Median (SD) MET h/wk
42 58 52 78 54 No of cases
682 970 702 710 532 859 942 886 560 547 Person years
0.05 0.64 (0.42 to 0.98) 0.90 (0.61 to 1.33) 1.01 (0.68 to 1.50) 0.92 (0.61 to 1.40) 1.00 Age adjusted (95% CI)
0.09 0.66 (0.43 to 1.02) 0.92 (0.62 to 1.37) 1.04 (0.70 to 1.53) 0.92 (0.61 to 1.40) 1.00 Multivariable adjusted (95% CI)†
Cumulative average vigorous
physical activity (MET h/wk):
21.0 (30.8) 7.4 (8.9) 3.7 (5.2) 0.5 (2.7) 0 (1.0) Median (SD) MET h/wk
46 49 67 69 53 No of cases
680 753 725 927 668 005 829 798 517 491 Person years
0.01 0.63 (0.42 to 0.94) 0.66 (0.44 to 0.98) 0.95 (0.66 to 1.36) 0.84 (0.58 to 1.22) 1.00 Age adjusted (95% CI)
0.02 0.65 (0.42 to 0.97) 0.67 (0.45 to 0.99) 0.96 (0.66 to 1.38) 0.84 (0.57 to 1.21) 1.00 Multivariable adjusted (95% CI)†
MET h/wk=metabolic equivalent task hours per week.
*Mean of physical activity over follow-up.
†Models adjusted for age (months), smoking (never, former, current), body mass index at baseline (<20, 20-24.9, 25-29.9, ≥30), oral contraceptive use (never,
former, current), hormone therapy (never, former, current, premenopause), appendicectomy (no, yes), geographic latitude of residence at age 30 (southern, middle,
northern, missing/unknown), cohort (National Nurses’ study, National Nurses’ Study II), and non-steroid anti-inflammatory drug use (<2 tablets/week, ≥2 tablets/week).
‡Defined as jogging, running, biking, swimming, tennis, aerobics, and other vigorous exercises.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;347:f6633 doi: 10.1136/bmj.f6633 (Published 14 November 2013) Page 8 of 10
RESEARCHTable 3| Physical activity and risk of ulcerative colitis in Nurses’ Health Study and Nurses’ Health Study II (1984-2010)
P for trend
Physical activity fifth
Variables Highest 4th 3rd 2nd Lowest
Updated physical activity* (MET
h/wk):
45.2 (33.2) 21.5 (5.0) 11.2 (2.9) 5.1 (1.8) 1.0 (1.0) Median (SD) MET h/wk
74 63 85 67 74 No of cases
688 514 692 548 689 222 684 398 667 291 Person years
0.70 0.96 (0.70 to 1.33) 0.82 (0.58 to 1.15) 1.10 (0.80 to 1.51) 0.88 (0.63 to 1.23) 1.00 Age adjusted (95% CI)
0.46 0.91 (0.65 to 1.26) 0.78 (0.56 to 1.10) 1.06 (0.78 to 1.46) 0.87 (0.62 to 1.21) 1.00 Multivariable adjusted (95% CI)†
Cumulative average physical
activity (MET h/wk):
41.4 (29.9) 21.6 (5.0) 13.0 (3.1) 7.2 (2.1) 2.6 (1.5) Median (SD) MET h/wk
73 71 80 72 67 No of cases
681 317 724 306 720 478 694 609 601 262 Person years
0.83 0.99 (0.71 to 1.38) 0.89 (0.64 to 1.25) 1.02 (0.73 to 1.41) 0.94 (0.68 to 1.32) 1.00 Age adjusted (95% CI)
0.56 0.93 (0.66 to 1.30) 0.85 (0.61 to 1.20) 0.98 (0.71 to 1.36) 0.92 (0.66 to 1.29) 1.00 Multivariable adjusted (95% CI)†
Updated vigorous physical
activity‡ (MET h/wk):
28.5 (29.8) 8.8 (5.1) 4.5 (2.4) 0.5 (1.0) 0 (0.02) Median (SD) MET h/wk
67 79 59 90 68 No of cases
682 970 702 710 532 859 942 886 560 547 Person years
0.64 0.90 (0.64 to 1.28) 1.01 (0.74 to 1.44) 0.90 (0.63 to 1.29) 0.99 (0.69 to 1.42) 1.00 Age adjusted (95% CI)
0.49 0.87 (0.61 to 1.23) 1.01 (0.72 to 1.41) 0.90 (0.63 to 1.29) 0.99 (0.69 to 1.42) 1.00 Multivariable adjusted (95% CI)†
Cumulative average vigorous
physical activity (MET h/wk):
21.0 (30.8) 7.4 (8.9) 3.7 (5.2) 0.5 (2.7) 0 (1.0) Median (SD) MET h/wk
72 66 86 71 68 No of cases
680 753 725 927 668 005 829 798 517 491 Person years
0.57 0.88 (0.63 to 1.22) 0.76 (0.54 to 1.07) 1.04 (0.76 to 1.44) 0.75 (0.53 to 1.05) 1.00 Age adjusted (95% CI)
0.40 0.84 (0.60 to 1.18) 0.73 (0.52 to 1.03) 1.02 (0.74 to 1.41) 0.74 (0.52 to 1.04) 1.00 Multivariable adjusted (95% CI)†
MET h/wk=metabolic equivalent task hours per week.
*Mean of physical activity over follow-up.
†Models adjusted for age (months), smoking (never, former, current), body mass index at baseline (<20, 20-24.9, 25-29.9, ≥30), oral contraceptive use (never,
former, current), hormone therapy (never, former, current, premenopause), appendicectomy (no, yes), geographic latitude of residence at age 30 (southern, middle,
northern, missing/unknown), cohort (National Nurses’ study, National Nurses’ Study II), and non-steroid anti-inflammatory drug use (<2 tablets/week, ≥2 tablets/week).
‡Defined as jogging, running, biking, swimming, tennis, aerobics, and other vigorous exercises.
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RESEARCHFigure
Flow of eligible participants in study. NHS=Nurses’ Health Study; NHSII=Nurses’ Health Study II; IBD=inflammatory bowel
disease
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